No single score captures the burden of treatment in people with cystic fibrosis (pwCF), according to systematic review study findings published in the Journal of Cystic Fibrosis.

Diabetes mellitus, more commonly known as diabetes, actually consists of many different types. Learn more about the ...

I am one of the lucky ones. This site contains general information about cystic fibrosis, as well as personal insight from the CF community. Opinions and experiences shared by members of our community ...

Attendance Allowance is for older people who have a health condition and need help to look after them, however the level of ...

Attendance Allowance helps with extra costs if you have a physical or mental disability or illness severe enough that makes it hard for you to look after yourself - it does not cover mobility needs.

Zhou, Kenneth Q. (BMath, 2013; MMath, 2015; PhD (Actuarial Science), 2019, University of Waterloo) joined the Department of Statistics and Actuarial Science on January 2nd, 2025, as an Associate ...

Background Cystic fibrosis (CF) is an incurable, progressive disease that affects multiple organs, causing burdensome symptoms. This study aimed to explore the palliative care needs in patients with ...

Gunnar Esiason isn't like most hockey players -- his ability to complete a shift often depended on how his cystic fibrosis was affecting him that day. Throughout his journey with CF, hockey became ...

Gunnar Esiason isn't like most hockey players -- his ability to complete a shift often depended on how his cystic fibrosis was affecting him that day. Throughout his journey with CF, hockey became a ...

As Vertex Pharmaceuticals reels from a painful trial readout for its pain candidate suzetrigine, the Boston biotech has chalked up a win in its specialty area of cystic fibrosis. The FDA has ...

Cystic fibrosis (CF) is a genetic condition that leads to the production of thick, sticky mucus, which can cause complications in multiple organs, including the sinuses, lungs, intestines ...

Vertex Pharmaceuticals said Friday the FDA has approved its next cystic fibrosis product Alyftrek, clearing the biotech to market a product designed to improve on Trikafta. William Blair analysts see ...